Visfatin, a novel adipokine, stimulates glucose uptake through the Ca2+-dependent AMPK–p38 MAPK pathway in C2C12 skeletal muscle cells

Journal of Molecular Endocrinology

Volumn 54, Issue 3, 2015, Pages 251-262

  Lee, Jung Ok ^a   Kim, Nami ^a   Lee, Hye Jeong ^a   Lee, Yong Woo ^a   Kim, Joong Kwan ^a   Kim, Hyung Ip ^a   Lee, Soo Kyung ^a   Kim, Su Jin ^a   Park, Sun Hwa ^a   Kim, Hyeon Soo ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Adipokine; AMPK; Calcium; Diabetes; Glucose transport

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; AMPK ALPHA2 SUBUNIT, MOUSE; CYTOKINE; GLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, MOUSE; SLC2A4 PROTEIN, MOUSE;

ANIMAL; CALCIUM SIGNALING; CELL LINE; ENZYME ACTIVATION; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; SKELETAL MYOBLAST; TRANSPORT AT THE CELLULAR LEVEL;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM SIGNALING; CELL LINE; CYTOKINES; ENZYME ACTIVATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; MAP KINASE SIGNALING SYSTEM; MICE; MYOBLASTS, SKELETAL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RATS;

EID: 84942806778     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0274     Document Type: Article

References (64)

1. Abbott MJ, Edelman AM & Turcotte LP 2009 CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 297 R1724-R1732. (doi:10. 1152/ajpregu. 00179. 2009)
2. Adeghate E 2008 Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Current Medicinal Chemistry 15 1851-1862. (doi:10. 2174/092986708785133004)
3. Antonescu C, Huang C, Niu W, Liu Z, Eyers PA, Heidenreich KA, Bilan PJ & Klip A 2005 Reduction of insulin-stimulated glucose uptake in L6 myotubes by the protein kinase inhibitor SB203580 is independent of p38MAPK activity. Endocrinology 146 3773-3781. (doi:10. 1210/en. 2005-0404)
4. Arner P 2006 Visfatin-a true or false trail to type 2 diabetes mellitus. Clinics in Endocrinology and Metabolism 91 28-30. (doi:10. 1210/jc. 2005-2391). ?
5. Bazuine M, Ouwens DM, Gomes de Mesquita DS & Maassen JA 2003 Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity. European Journal of Biochemistry 270 3891-3903. (doi:10. 1046/j. 1432-1033. 2003. 03771. x)
6. Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P et al. 2009 Disruption of the Ang II type 1 receptor promotes longevity in mice. Journal of Clinical Investigation 119 524-530. (doi:10. 1172/JCI36703)
7. Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon MR, Stumvoll M & Blüher M 2005 Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54 2911-2916. (doi:10. 2337/diabetes. 54. 10. 2911)
8. Brown JE, Onyango DJ, RamanjaneyaM, Conner AC, Patel ST, Dunmore SJ & Randeva HS 2010 Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic β-cells. Journal of Molecular Endocrinology 44 171-178. (doi:10. 1677/JME-09-0071)
9. Cheng Z, Pang T, Gu M, Gao AH, Xie CM, Li JY, Nan FJ & Li J 2006 Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochimica et Biophysica Acta 1760 1682-1689. (doi:10. 1016/j. bbagen. 2006. 09. 007)
10. Godl K, Wissing J, Kurtenbach A, Habenberger P, Blencke S, Gutbroad H, Salassidis K, Stein-Gerlach M, Missio A, Cotton Met et al. 2003 An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. PNAS 100 15434-15439. (doi:10. 1073/pnas. 2535024100)
11. Goodyear LJ, Chang PY, Sherwood DJ, Dufresne SD & Moller DE 1996 Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. American Journal of Physiology 271 E403-E408.
12. Haider DG, Schaller G, Kapiotis S, Maier C, Luger A & Wolzt M 2006 The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49 1909-1914. (doi:10. 1007/s00125-006-0303-7)
13. HallschmidM, Randeva H, Tan BK, KernW& Lehnert H 2009 Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans. Diabetes 58 637-640. (doi:10. 2337/db08-1176)
14. Hammarstedt A, Pihlajamaki J, Sopasakis VR, Gogg S, Jansson PA, LaaksoM & Smith U 2006 Visfatin is an adipokine, but it is not regulated by thiazolidinediones,. Journal of Clinical Endocrinology and Metabolism 91 1181-1184. (doi:10. 1210/jc. 2005-1395)
15. Harasim E, Chabowski A & Gorski J 2011 Lack of downstream insulinmimetic effects of visfatin/eNAMPT on glucose and fatty acid metabolism in skeletal muscles. Acta Physiologica 202 21-28. (doi:10. 1111/j. 1748-1716. 2011. 02254. x)
16. Hardie DG & Carling D 1998 The AMP-activated protein kinase-fuel gauge of the mammalian cell? European Journal of Biochemistry 246 259-273. (doi:10. 1111/j. 1432-1033. 1997. 00259. x)
17. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG & Hardie DG 2005 Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metabolism 2 9-19. (doi:10. 1016/j. cmet. 2005. 05. 009). ?
18. Hayashi T, Hirshman MF, Kurth EJ, Winder WW & Goodyear LJ 1998 Evidence for 50 AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47 1369-1373. (doi:10. 2337/diab. 47. 8. 1369)
19. Henin N, Vincent MF, Gruber HE & Van den Berghe G 1995 Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB Journal 9 541-546.
20. Henriksen EJ, Bourey RE, Rodnick KJ, Koranyi L, PermuttMA & Holloszy JO 1990 Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. American Journal of Physiology 259 E593-E598.
21. 2C/calmodulin-dependent protein kinase kinase α as Snf1-activating kinases in yeast. Journal of Biological Chemistry 280 21804-21809. (doi:10. 1074/jbc. M501887200)
22. Huang S & Czech MP 2007 The GLUT4 glucose transporter. Cell Metabolism 5 237-252. (doi:10. 1016/j. cmet. 2007. 03. 006)
23. 2C/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. Journal of Biological Chemistry 280 29060-29066. (doi:10. 1074/jbc. M503824200)
24. Jensen TE, Rose AJ, Jørgensen SB, Brandt N, Schjerling P, Wojtaszewski JF & Richter EA 2007 Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction. American Journal of Physiology. Endocrinology and Metabolism 292 E1308-E1317. (doi:10. 1152/ajpendo. 00456. 2006)
25. Kahn BB 1996 Glucose transport: pivotal step in insulin action. Diabetes 45 1644-1654. (doi:10. 2337/diab. 45. 11. 1644)
26. Kang ES, Magkos F, Sienkiewicz E & Mantzoros CS 2011 Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans. European Journal of Endocrinology 164 911-917. (doi:10. 1530/EJE-11-0052)
27. Klip A & Marette A 1992 Acute and chronic signals controlling glucose transport in skeletal muscle,. Journal of Cellular Biochemistry 48 51-60. (doi:10. 1002/jcb. 240480109)
28. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T & Klip A 2001 The antihyperglycemic drug α-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 50 1464-1471. (doi:10. 2337/diabetes. 50. 6. 1464)
29. Krook A, Wallberg-Henriksson H & Zierath JR 2004 Sending the signal: molecular mechanisms regulating glucose uptake. Medicine and Science in Sports and Exercise 36 1212-1217. (doi:10. 1249/01. MSS. 0000132387. 25853. 3B)
30. Laudes M, Oberhauser F, Schulte DM, Freude S, Bilkovski R, Mauer J, Rappl G, Abken H, Hahn M, Schulz O et al. 2010 Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans. Hormone and Metabolic Research 42 268-273. (doi:10. 1055/s-0029-1243638)
31. Lee YM, Lee JO, Jung JH, Kim JH, Park SH, Park JM, Kim EK, Suh PG & Kim HS 2008 Retinoic acid leads to cytoskeletal rearrangement through AMPK-Rac1 and stimulates glucose uptake through AMPK-p38 MAPK in skeletal muscle cells. Journal of Biological Chemistry 283 33969-33974. (doi:10. 1074/jbc. M804469200)
32. Lemieux K, Konrad D, Klip A & Marette A 2003 The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases α and β in skeletal muscle. FASEB Journal 17 1658-1665. (doi:10. 1096/fj. 02-1125com)
33. Li J, Houseknecht KL, Stenbit AE, Katz EB & Charron MJ 2000 Reduced glucose uptake precedes insulin signaling defects in adipocytes from heterozygous GLUT4 knockout mice. FASEB Journal 14 1117-1125.
34. Li H, Liu P, Cepeda J, Fang D, Easley RB, Simon BA, Zhang LQ & Ye SQ 2008 Augmentation of pulmonary epithelial cell IL-8 expression and permeability by pre-B-cell colony enhancing factor. Journal of Inflammation 5 15. (doi:10. 1186/1476-9255-5-15)
35. Makinde AO, Gamble J & Lopaschuk GD 1997 Upregulation of 50-AMPactivated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit. Circulation Research 80 482-489. (doi:10. 1161/01. RES. 80. 4. 482)
36. Michelle Furtado L, Poon V & Klip A 2003 GLUT4 activation: thoughts on possible mechanisms. Acta Physiologica Scandinavica 178 287-296. (doi:10. 1046/j. 1365-201X. 2003. 01160. x)
37. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H & Tilg H 2007 Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. Journal of Immunology 178 1748-1758. (doi:10. 4049/jimmunol. 178. 3. 1748)
38. Mu J, Brozinick JT Jr, Valladares O, BucanM& Birnbaum MJ 2001 A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Molecular Cell 7 1085-1094. (doi:10. 1016/S1097-2765(01)00251-9). ?
39. Nakahata Y, Sahar S, Astarita G, Kaluzova M & Sassone-Corsi P 2009 Circadian control of the NADC salvage pathway by CLOCK-SIRT1. Science 324 654-657. (doi:10. 1126/science. 1170803)
40. Naz R, Hameed W, Hussain MM & Aslam M 2011 Glucose lowering effect of visfatin in obese and insulin dependent diabetes mellitus. Pakistan Journal of Physiology 7 4-7.
41. Ramsey KM, Yoshino J, Brace CS, Abrassart D, Kobayashi Y, Marcheva B, Hong HK, Chong JL, Buhr ED, Lee C et al. 2009 Circadian clock feedback cycle through NAMPT-mediated NADC biosynthesis. Science 324 651-654. (doi:10. 1126/science. 1171641)
42. Ren JM, Semenkovich CF, Gulve EA, Gao J & Holloszy JO 1994 Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle. Journal of Biological Chemistry 269 14396-14401.
43. Revollo JR, Körner A, Mills KF, Satoh A, Wang T, Garten A, Dasgupta B, Sasaki Y, Wolberger C, Townsend RR et al. 2007 Nampt/PBEF/visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme. Cell Metabolism 6 363-375. (doi:10. 1016/j. cmet. 2007. 09. 003). ?
44. Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O & Andris F 2002 Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. European Journal of Immunology 32 3225-3234. (doi:10. 1002/1521-4141(200211)32: 11!3225::AID-IMMU3225O3. 0. CO;2-L)
45. Rongvaux A, GalliM, Denanglaire S, VanGool F, Dreze PL, Szpirer C, Bureau F, Andris F & Leo O 2008 Nicotinamide phosphoribosyl transferase/ pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress. Journal of Immunology 181 4685-4695. (doi:10. 4049/jimmunol. 181. 7. 4685)
46. Rossetti L, Stenbit AE, Chen W, Hu M, Barzilai N, Katz EB & Charron MJ 1997 Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene. Journal of Clinical Investigation 100 1831-1839. (doi:10. 1172/ JCI119711)
47. Samal B, Sun Y, Stearns G, Xie C, Suggs S & McNiece I 1994 Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology 14 1431-1437. (doi:10. 1128/MCB. 14. 2. 1431)
48. Sarabia V, Ramlal T & Klip A 1990 Glucose uptake in human and animal muscle cells in culture. Biochemistry and Cell Biology 68 536-542. (doi:10. 1139/o90-076)
49. Sethi JK & Vidal-Puig A 2005 Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends in Molecular Medicine 11344-347. (doi:10. 1016/j. molmed. 2005. 06. 010)
50. Sinclair DA 2005 Toward a unified theory of caloric restriction and longevity regulation. Mechanisms of Ageing and Development 126 987-1002. (doi:10. 1016/j. mad. 2005. 03. 019)
51. Sommer G, Garten A, Petzold S, Beck-Sickinger AG, Bluher M, Stumvoll M & Fasshauer M 2008 Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clinical Science 115 13-23. (doi:10. 1042/CS20070226)
52. Somwar R, Kim DY, Sweeney G, Huang C, Niu W, Lador C, Ramlal T & Klip A 2001 GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase. Biochemical Journal 359 639-649. (doi:10. 1042/0264-6021:3590639)
53. Stenbit AE, Tsao TS, Li J, Burcelin R, Geenen DL, Factor SM, Houseknecht K, Katz EB & Charron MJ 1997 GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nature Medicine 3 1096-1101. (doi:10. 1038/nm1097-1096)
54. Thong FS, Bilan PJ & Klip A 2007 The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes 56 414-423. (doi:10. 2337/ db06-0900)
55. Treebak JT, Glund S, Deshmukh A, Klein DK, Long YC, Jensen TE, Jørgensen SB, Viollet B, Andersson L, Neumann D et al. 2006 AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 55 2051-2058. (doi:10. 2337/db06-0175)
56. Tsao TS, Burcelin R, Katz EB, Huang L & CharronMJ 1996 Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45 28-36. (doi:10. 2337/diab. 45. 1. 28)
57. Tsao TS, Li J, Chang KS, Stenbit AE, Galuska D, Anderson JE, Zierath JR, McCarter RJ & Charron MJ 2001 Metabolic adaptations in skeletal muscle overexpressing GLUT4: effects on muscle and physical activity. FASEB Journal 15 958-969. (doi:10. 1096/fj. 00-0381)
58. Wanecq E, Prevot D & Carpene C 2009 Lack of direct insulin-like action ofvisfatin/NAMPT/PBEF1 in human adipocytes,. Journal of Physiology and Biochemistry 65 351-359. (doi:10. 1007/BF03185930). ?
59. Widegren U, Jiang XJ, Krook A, Chibalin AV, Björnholm M, Tally M, Roth RA, Henriksson J, Wallberg-henriksson H & Zierath JR 1998 Divergent effects of exercise on metabolic and mitogenic signaling pathways in human skeletal muscle. FASEB Journal 12 1379-1389.
60. 2C and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes 53 330-335. (doi:10. 2337/diabetes. 53. 2. 330)
61. Xie H, Tang SY, Luo XH, Huang J, Cui RR, Yuan LQ, Zhou HD, Wu XP & Liao EY 2007 Insulin-like effects of visfatin on human osteoblasts. Calcified Tissue International 80 201-210. (doi:10. 1007/s00223-006-0155-7)
62. Yamaguchi S, Katahira H, Ozawa S, Nakamichi Y, Tanaka T, Shimoyama T, Takahashi K, Yoshimoto K, Imaizumi MO, Nagamatsu S et al. 2005 Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes. American Journal of Physiology. Endocrinology and Metabolism 289 E643-E649. (doi:10. 1152/ajpendo. 00456. 2004)
63. Yang H, Yang T, Baur JA, Perez E, Matsui T, Carmona JJ, Lamming DW, Souza-Pinto NC, Bohr VA, Rosenzweig A et al. 2007 Nutrient-sensitive mitochondrial NADC levels dictate cell survival. Cell 130 1095-1107. (doi:10. 1016/j. cell. 2007. 07. 035)
64. Zong H, Ren JM, Young LH, Pypaert M, Mu J, Birnbaum MJ & Shulman GI 2002 AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. PNAS 99 15983-15987. (doi:10. 1073/pnas. 252625599)